InvestorsHub Logo
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

Re: None

Monday, 12/04/2017 7:14:46 AM

Monday, December 04, 2017 7:14:46 AM

Post# of 1434
January 11, 2018: Antimicrobial Drugs Advisory Committee public meeting (Hyattsville, MD) - The committee will discuss new drug application (NDA) 210693, ciprofloxacin dispersion for inhalation, sponsored by Aradigm Corp., for the proposed indication of treatment of non-cystic fibrosis bronchiectasis patients with chronic lung infections with Pseudomonas aeruginosa.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.